[1] Katsimardou A, Stavropoulos K, Imprialos K,et al. Hypertension and hyperhomocysteinemia as risk factors for chronic kidney disease: a dangerous duo?[J]. J Clin Hypertens, 2019, 21(10)1578-1579. [2] Cytemel C,Topaloglu Demir F, Buyukbabani N, et al. Multifactorial painful leg ulcers due to hyperhomocysteinemia, plasminogen activator inhibitor-1 4G/5G heterozygote gene mutation, and beta thalassemia minor: a case report[J]. Int J Low Extr Wound, 2019, 18(3):339-341. [3] Yu PM,Shcherbitskaia AD,Zalozniaia IV,et al. Neurotrophic factors and inflammatory cytokines in the mother-placenta-fetus system in experimental hyperhomocysteinemia[J]. Int J Med Acad, 2019, 19(1):230-231. [4] 姜金钟,苗维,田守森,等.H型高血压患者动态血压变异性及动脉硬化特点的临床研究[J].中国循证心血管医学杂志,2018,10(2):190-192,195. [5] 中国高血压防治指南修订委员会.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. [6] 中国高血压防治指南修订委员会.中国高血压防治指南[J].中华心血管病杂志,2011,39(7):584-587. [7] Varlamos C, Pappas C, Kiouri E, et al. Hyperhomocysteinemia as the only risk factor in a young man presenting with ST-elevation myocardial infarction[J]. J Cardiol Cases, 2020,23(3):112-114. [8] Singh S, Sreenivasulu P, Patnaik S, et al. Anesthesia management of a case of hyperhomocysteinemia induced mesenteric venous thrombosis and short review of literature[J]. J Anaesth Clin Pharm, 2021, 37(1):132-133. [9] Vasilev DS,Shcherbitskaia AD,Tumanova NL,et al. Prenatal hyperhomocysteinemia disturbs the mechanisms of development of the cerebral cortex in rats[J]. Zhurnal Evoliutsionno Biokhimii Fiziologii, 2020, 56(7):808-808. [10] 柳明波,周成萍,黄素兰,等.钦州市1 005名老年人高同型半胱氨酸血症危险因素分析[J]. 实用预防医学,2020,27(12):90-93. [11] 薛红红, 田晶, 徐建荣,等. 太原市4 420例H型高血压病人血浆同型半胱氨酸水平及相关因素分析[J]. 中西医结合心脑血管病杂志, 2019, 17(9):28-31. [12] 周建军, 倪一宏, 张艳,等. 上海市黄浦区老年高血压人群同型半胱氨酸流行特征及心脑血管疾病风险分析[J]. 老年医学与保健, 2019, 25(2):151-154,173. [13] Elsaid HH, El-Hefnawy KA, Elalawi SM . C677T MTHFR gene polymorphism is contributing factor in development of renal impairment in young hypertensive patients[J]. Indian J Clin Biochem, 2021,36(2):213-220. [14] 张波,叶丛. H型高血压合并非致残性缺血性脑血管事件病人血压变异性与颈动脉粥样硬化的相关性分析[J]. 中西医结合心脑血管病杂志, 2020, 18(20):152-155. [15] 葛君,汪朝晖,宣玲.高血压患者血清hs-CRP、Hcy及UA水平与颈动脉粥样硬化的相关性研究[J].中华全科医学,2019,17(7):1138-1141. [16] 谢军, 孙媛媛, 余其贵,等. 高血压人群中超敏C反应蛋白,尿酸及同型半胱氨酸水平与臂踝脉搏波传导速度关系的研究[J]. 现代生物医学进展, 2020, 20(9):91-94. [17] 王铖,桑婉玥,吕忠英,等.脉搏波传导速度与中青年原发性高血压患者早期肾损害的相关性及诊断价值[J].中国动脉硬化杂志,2020,28(1):44-48. [18] 马博聪, 赵明, 刘颖,等. 不同时间服用依那普利叶酸片对高龄H型高血压患者昼夜节律及同型半胱氨酸水平的影响[J]. 中国循证心血管医学杂志, 2020, 12(1):29-31. [19] 许海华,徐明星,王砚青,等.马来酸依那普利叶酸片对高血压伴高同型半胱氨酸血症患者颈动脉粥样硬化的影响及相关机制研究[J].世界临床药物,2018,39(8):549-554.